Actinium Pharmaceuticals, Inc. (ATNM)
1.17
+0.08
(+7.34%)
USD |
NYAM |
Apr 07, 16:00
1.17
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals Shareholders Equity (Quarterly) : 7.834M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 93.95M |
| Altimmune, Inc. | 224.89M |
| Aldeyra Therapeutics, Inc. | 44.25M |
| Avanos Medical, Inc. | 778.20M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 52.21M |
| Total Liabilities (Quarterly) | 44.37M |
| Debt to Equity Ratio | 0.2162 |
| Current Ratio | 6.197 |
| Net Debt Paydown Yield | 0.01% |